Telisotuzumab vedotin and osimertinib: the METamorphosis of epidermal growth factor receptor-mutant lung cancer?

J. Remon, S. P.L. Saw

Résultats de recherche: Contribution à un journal › Editorial

Accès au document

@article{2d828345c632442d9554d8bac7ccfafc,

title = "Telisotuzumab vedotin and osimertinib: the METamorphosis of epidermal growth factor receptor-mutant lung cancer?",

author = "J. Remon and Saw, {S. P.L.}",

year = "2025",

month = may,

day = "1",

doi = "10.1016/j.annonc.2025.01.008",

language = "English",

volume = "36",

pages = "484--487",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "5",

}

TY - JOUR

T1 - Telisotuzumab vedotin and osimertinib

T2 - the METamorphosis of epidermal growth factor receptor-mutant lung cancer?

AU - Remon, J.

AU - Saw, S. P.L.

PY - 2025/5/1

Y1 - 2025/5/1

UR - http://www.scopus.com/inward/record.url?scp=85217957026&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2025.01.008

DO - 10.1016/j.annonc.2025.01.008

M3 - Editorial

C2 - 39855428

AN - SCOPUS:85217957026

SN - 0923-7534

VL - 36

SP - 484

EP - 487

JO - Annals of Oncology

JF - Annals of Oncology

IS - 5

ER -